MARKET NEWS - Page 294

Commodity stocks weigh on UK’s FTSESubscriber Only

May 5, 2011 02:31 IST

Commodity stocks dragged Britain's top share index lower on Wednesday,ending the FTSE 100's recent rally as disappointing U.S. manufacturing data spoiled investors' appetite for risk.

Dr Reddy’s stock drops over 5%Subscriber Only

May 4, 2011 18:41 IST

Dr Reddy's Laboratories fell by 5% amid media reports that a US drug maker has sued it.

Cox & Kings shares up 7% on stock-splitSubscriber Only

April 28, 2011 09:35 IST

At 10.02 a.m.,shares of the company were up 6.4 per cent to be at Rs 438.80.

Gold has underperformed Sensex over last three decades: FE studySubscriber Only

April 28, 2011 03:58 IST

The recent rise in gold prices towards an all-time high of $1,507 an ounce in the international market has added to the regard gold generally receives from Indian retail investors.

Bric stock rally may plungeSubscriber Only

April 20, 2011 03:58 IST

The longest rally in developing nation stocks since 1997 may be ending as higher interest rates in Brazil,Russia,India and China curb earnings growth.

Invest in short-term income fundsSubscriber Only

April 20, 2011 03:43 IST

We are recommending income funds to investors as they will give good returns,says Canara MF's Jain.

Sebi board to reconsider NSDL caseSubscriber Only

April 20, 2011 03:25 IST

Sebi had rejected 20008 report on IPO scam that indicted NSDL.

Wipro,TCS stay top picksSubscriber Only

April 16, 2011 03:54 IST

We believe the rupee EPS guidance for FY12 was very disappointing. Management guided for 18-20% US dollar revenue growth in FY12,which is in line with our expectation of guidance.

Sesa Goa stock gets ‘buy’ ratingSubscriber Only

April 11, 2011 00:22 IST

Lifting of export ban improves visibility on volume growth.

‘Buy’ Bharat Heavy Electricals stockSubscriber Only

April 11, 2011 00:20 IST

BHELs annual profit after tax at R60.2 bn was up 40% YoY on strong sales growth of 27% YoY and margin expansion as staff costs fell to 13% of sales and RM as a percentage of sales came off 130 bps.

Q4 Preview: Telecom stocks outlookSubscriber Only

April 11, 2011 00:17 IST

We expect robust volume growth to sustain for the GSM incumbents Bharti and Idea and remain muted for RCom on account of the ongoing portfolio rebalancing.

Q4 Results Preview: Pharma stocksSubscriber Only

April 11, 2011 00:15 IST

We expect Dr Reddys and Cadila Healthcare,among large caps,to report strong numbers,while in mid-caps,Aurobindo Pharma and Ipca Laboratories will have strong traction.

Q4 Results Preview: IT Services ratingSubscriber Only

April 11, 2011 00:12 IST

The fourth quarter would be relatively weak in line with seasonal trends,but...

US stocks dip after quake hits JapanSubscriber Only

April 8, 2011 03:40 IST

Stocks are ending the day with small losses after a 7.4-magnitude earthquake struck Japan.

Commodities top asset class of FY11Subscriber Only

April 7, 2011 02:58 IST

Commodities is increasingly turning out to be a promising asset class that investors cant just ignore.

US stocks end mixed; materials cos upSubscriber Only

April 6, 2011 02:07 IST

Wall Street left stock indexes little changed after minutes from the most recent meeting of the Federal Reserve's policy committee...

Realty stock index worst,large caps topSubscriber Only

April 1, 2011 10:23 IST

For most of fiscal 2010-11,Indian stock market outdid developed markets including the US.

Time to look at selective mid-capsSubscriber Only

March 30, 2011 00:20 IST

BSE small-cap/mid-cap indices underperformed the Sensex by 19.5% and 13.4%.

‘Investors not bullish on local markets’Subscriber Only

March 30, 2011 00:14 IST

62% of investors plan to invest in global markets

Sesa Goa stock gets ‘Reduce’ ratingSubscriber Only

March 28, 2011 01:14 IST

We initiate coverage of MOIL,Indias largest manganese ore producer,with a Reduce rating and a target price of R337 based on 6.0x FY12e EV/Ebitda.

Aurobindo Pharma stock gets ‘Buy’ ratingSubscriber Only

March 28, 2011 01:11 IST

We initiate coverage on Aurobindo with a Buy rating and PO of R262. Our PO is pegged at 13.5x FY12e,25% discount to peers to factor import alert by FDA.

Ranbaxy Laboratories stock rated ‘Buy’Subscriber Only

March 28, 2011 01:09 IST

Mylans suit against the US FDA seeks clarity on whether Ranbaxys ANDA for Lipitor is approvable something that most investors are keen to know as well.

Grasim Industries stock gets ‘Buy’ ratingSubscriber Only

March 28, 2011 01:07 IST

Grasim offers exposure to both cement and VSF and we feel it offers either a cheap entry into cement or cheap entry into a robust VSF outlook,or an attractively valued combination of the two.